AI assistant
Fagron N.V. — Major Shareholding Notification 2011
Jul 1, 2011
3949_mrq_2011-07-01_5501379f-254d-45c0-add6-92c10733e80a.pdf
Major Shareholding Notification
Open in viewerOpens in your device viewer
DISCLOSURE OF RECEIVED NOTIFICATION DISCLOSURE
Waregem (Belgium) / Rotterdam (The Netherlands)1 , 1 July 2011 (7:30 am) – Pursuant to the Belgian legislation of 2 May 2007 relating to the disclosure of major shareholdings in listed companies, Arseus received notification on 23 June 2011 that the shareholding of BNP Paribas Investment Partners SA (formerly Fortis Investment Management SA) on 17 May 2011 had fallen below the disclosure threshold of 5%.
Based on the denominator of 31,216,888 (total number of voting rights) and the relevant notifications received by Arseus, today the shareholder structure of Arseus is as follows:
| Number of shares | % of total | |
|---|---|---|
| EnHold NV | 8,166,908 | 26.16% |
| Couckinvest NV/Coucke | 3,528,080 | 11.30% |
| BNP Paribas Investment Partners SA | 1,546,052 | 4.95% |
| Arseus NV | 1,105,585 | 3.54% |
| Public | 16,870,263 | 54.05% |
The original notification forms are also available on the corporate website of Arseus (www.arseus.com).
For more information:
Constantijn van Rietschoten Director of Corporate Communications +31 88 33 11 222 (office) +31 6 536 91 585 (mobile) [email protected]
In the event of any discrepancy between the English translation and the original Dutch version of this press release, the latter shall prevail.
1 This press release was sent out by Arseus NV and Arseus BV.
Arseus Profile
Arseus is a multinational group of companies that supplies products, services and concepts to professionals and institutions in the healthcare sector in Europe, the US and Brazil. Arseus is subdivided into four divisions and operates in the markets for pharmaceutical compounding for pharmacies, dental products, medical and surgical products, and medical ICT-solutions. The Belgian company Arseus NV is located in Waregem, and is listed on NYSE Euronext Brussels and NYSE Euronext Amsterdam. The operational activities of the Arseus group are driven by the Dutch company Arseus BV. The head office of Arseus BV is located in Rotterdam.